EIF4ENIF1 Human Pre-designed siRNA Set A contains three designed siRNAs for EIF4ENIF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EIF4G1 Human Pre-designed siRNA Set A contains three designed siRNAs for EIF4G1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EIF4G2 Human Pre-designed siRNA Set A contains three designed siRNAs for EIF4G2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EIF4G3 Human Pre-designed siRNA Set A contains three designed siRNAs for EIF4G3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EIF4H Human Pre-designed siRNA Set A contains three designed siRNAs for EIF4H gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EIF5 Human Pre-designed siRNA Set A contains three designed siRNAs for EIF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EIF5A Human Pre-designed siRNA Set A contains three designed siRNAs for EIF5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EIF5A2 Human Pre-designed siRNA Set A contains three designed siRNAs for EIF5A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EIF5B Human Pre-designed siRNA Set A contains three designed siRNAs for EIF5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EIF6 Human Pre-designed siRNA Set A contains three designed siRNAs for EIF6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELAC1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELAC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELAC2 Human Pre-designed siRNA Set A contains three designed siRNAs for ELAC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Elacestrant-d10 is the deuterium labeled of Elacestrant (HY-19822). Elacestrant is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also inhibits growth of ER+ breast cancer cell lines in vitro and in vivo[1][2].

Elacestrant-d4 (RAD1901-d4) is deuterated labeled Elacestrant (HY-19822) Elacestrant (RAD1901) is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also can inhibit growth of ER+ breast cancer cell lines in vitro and in vivo.

Elacestrant-d4-1 is the deuterium labeled Elacestrant (HY-19822). Elacestrant is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively[1][2].

Elacestrant-d6 (RAD1901-d6) is deuterated labeled Elacestrant (HY-19822) Elacestrant (RAD1901) is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also can inhibit growth of ER+ breast cancer cell lines in vitro and in vivo.

Elamipretide TFA (MTP-131 TFA; RX-31 TFA; SS-31 TFA) is the TFA salt form of Elamipretide (HY-P0125). Elamipretide TFA is a mitochondria-targeting peptide, which ameliorates myocardial infarction, improves the renal function and protects neurons form inflammatory and oxidative stress injury[1][2].

Elamipretide TFA (MTP-131 TFA; RX-31 TFA; SS-31 TFA) is the TFA salt form of Elamipretide (HY-P0125). Elamipretide TFA is a mitochondria-targeting peptide, which ameliorates myocardial infarction, improves the renal function and protects neurons form inflammatory and oxidative stress injury[1][2].

Elamipretide TFA (MTP-131 TFA; RX-31 TFA; SS-31 TFA) is the TFA salt form of Elamipretide (HY-P0125). Elamipretide TFA is a mitochondria-targeting peptide, which ameliorates myocardial infarction, improves the renal function and protects neurons form inflammatory and oxidative stress injury[1][2].

Elamipretide triacetate (MTP-131 triacetate; RX-31 triacetate; SS-31 triacetate) is Elamipretide triacetate form of Elamipretide (HY-P0125). Elamipretide triacetate is a mitochondria-targeting peptide, which ameliorates myocardial infarction, improves the renal function and protects neurons form inflammatory and oxidative stress injury[1][2].

Elamipretide triacetate (MTP-131 triacetate; RX-31 triacetate; SS-31 triacetate) is Elamipretide triacetate form of Elamipretide (HY-P0125). Elamipretide triacetate is a mitochondria-targeting peptide, which ameliorates myocardial infarction, improves the renal function and protects neurons form inflammatory and oxidative stress injury[1][2].

Elamipretide triacetate (MTP-131 triacetate; RX-31 triacetate; SS-31 triacetate) is Elamipretide triacetate form of Elamipretide (HY-P0125). Elamipretide triacetate is a mitochondria-targeting peptide, which ameliorates myocardial infarction, improves the renal function and protects neurons form inflammatory and oxidative stress injury[1][2].

Elamipretide triacetate (MTP-131 triacetate; RX-31 triacetate; SS-31 triacetate) is Elamipretide triacetate form of Elamipretide (HY-P0125). Elamipretide triacetate is a mitochondria-targeting peptide, which ameliorates myocardial infarction, improves the renal function and protects neurons form inflammatory and oxidative stress injury[1][2].

Elamipretide triacetate (MTP-131 triacetate; RX-31 triacetate; SS-31 triacetate) is Elamipretide triacetate form of Elamipretide (HY-P0125). Elamipretide triacetate is a mitochondria-targeting peptide, which ameliorates myocardial infarction, improves the renal function and protects neurons form inflammatory and oxidative stress injury[1][2].

Elamipretide triacetate (MTP-131 triacetate; RX-31 triacetate; SS-31 triacetate) is Elamipretide triacetate form of Elamipretide (HY-P0125). Elamipretide triacetate is a mitochondria-targeting peptide, which ameliorates myocardial infarction, improves the renal function and protects neurons form inflammatory and oxidative stress injury[1][2].

ELANE Human Pre-designed siRNA Set A contains three designed siRNAs for ELANE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELAPOR1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELAPOR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Elastin from pig (Elastin) is a key matrix protein that imparts elasticity to organs and tissues. Elastin from pig is a stable, insoluble protein, and utilized in biomaterial for human tissue repairment[1].

Elastin Methacrylated (ElaMA) elastin recruits and modulates innate immune cells and accelerates angiogenesis at the wound site, thereby improving wound regeneration. Elastin Methacrylated attracts large numbers of neutrophils and primarily M2 macrophages to the wound and induces their penetration into the hydrogel. Elastin Methacrylated has excellent immunomodulatory effects, leading to superior angiogenesis, collagen deposition and […]

ELAVL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELAVL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELAVL2 Human Pre-designed siRNA Set A contains three designed siRNAs for ELAVL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELAVL3 Human Pre-designed siRNA Set A contains three designed siRNAs for ELAVL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELAVL4 Human Pre-designed siRNA Set A contains three designed siRNAs for ELAVL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Elemicin-d3 is deuterated labeled Pemafibrate (HY-17618). Pemafibrate is a highly selective PPARα agonist, with an EC50 of 1 nM.

ELF1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELF2 Human Pre-designed siRNA Set A contains three designed siRNAs for ELF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELF3 Human Pre-designed siRNA Set A contains three designed siRNAs for ELF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELF4 Human Pre-designed siRNA Set A contains three designed siRNAs for ELF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELF5 Human Pre-designed siRNA Set A contains three designed siRNAs for ELF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELFN1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELFN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELFN2 Human Pre-designed siRNA Set A contains three designed siRNAs for ELFN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Elinafide is an anticancer agent with a naphthalimide structure that targets DNA. Elinafide interferes with cell metabolism by inserting a planar ring into the DNA double helix and interacting with enzymes through its side chain. The IC50 value of Elinafide for HT-29 cells is 0.014 μM[1].

Elinafide is an anticancer agent with a naphthalimide structure that targets DNA. Elinafide interferes with cell metabolism by inserting a planar ring into the DNA double helix and interacting with enzymes through its side chain. The IC50 value of Elinafide for HT-29 cells is 0.014 μM[1].

Elinafide is an anticancer agent with a naphthalimide structure that targets DNA. Elinafide interferes with cell metabolism by inserting a planar ring into the DNA double helix and interacting with enzymes through its side chain. The IC50 value of Elinafide for HT-29 cells is 0.014 μM[1].

Elinafide is an anticancer agent with a naphthalimide structure that targets DNA. Elinafide interferes with cell metabolism by inserting a planar ring into the DNA double helix and interacting with enzymes through its side chain. The IC50 value of Elinafide for HT-29 cells is 0.014 μM[1].

Elinafide is an anticancer agent with a naphthalimide structure that targets DNA. Elinafide interferes with cell metabolism by inserting a planar ring into the DNA double helix and interacting with enzymes through its side chain. The IC50 value of Elinafide for HT-29 cells is 0.014 μM[1].

Elismetrep (MT-8554) is an oral active TRPM8 inhibitor, and can be used for study of analgesic[1][2].

ELK1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELK3 Human Pre-designed siRNA Set A contains three designed siRNAs for ELK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.